Who are the 15 major players in the global orthobiologics market?

Shayna Korol -   Print  |

The global orthobiologics market is expected to grow from $4.66 billion in 2017 to reach $8.06 billion by 2023, increasing at a 5.7 percent compound annual growth rate, according to a Market.Biz report.

The major players in the global orthobiologics market include:

1. Stryker

2. RTI Surgical

3. Bioventus

4. Zimmer Biomet

5. Seaspine

6. Kuros Biosciences

7. Globus Medical

8. Xtant Medical

9. Harvest Technologies

10. Nuvasive

11. Orthofix International

12. Arthrex

13. Medtronic

14. K2M

15. DePuy Synthes

More articles on biologics:

Tissue Regenix group inks deal, expands DermaPure access in US

Biologica Technologies to exhibit ProteiOS data at AANS Annual Meeting: 3 insights

Infuse gets new FDA indication for lateral, anterior spinal fusions with PEEK implants: 5 things to know

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers